Bioceres director reports 150K stock options

Bioceres Crop Solutions Corp. director Duraiswami Narain reported initial holdings of stock options representing the right to buy 150,000 Ordinary Shares.

Rhea-AI Filing Summary

Bioceres Crop Solutions Corp. director Duraiswami Narain reported initial holdings of stock options representing the right to buy 150,000 Ordinary Shares. The options have an exercise price of $1.50 per share, become exercisable on June 30, 2028, and expire on June 30, 2033. All holdings in this filing are reported as held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Duraiswami Narain

Role Director

Type	Security	Shares	Price	Value
holding	Stock Options representing a right to buy	--	--	--

Holdings After Transaction: Stock Options representing a right to buy — 150,000 contracts (Direct)

Key Figures

Underlying option shares: 150,000 shares Exercise price: $1.50 per share Option exercise date: June 30, 2028 +1 more

4 metrics

Underlying option shares 150,000 shares Ordinary Shares underlying reported stock options

Exercise price $1.50 per share Stock option exercise price

Option exercise date June 30, 2028 Date options become exercisable

Option expiration date June 30, 2033 Date options expire

Key Terms

Stock Options, Ordinary Shares, exercise price, expiration date

4 terms

Stock Options financial

"Stock Options representing a right to buy"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

Ordinary Shares financial

"underlying_security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"conversion_or_exercise_price: 1.5000"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2033-06-30T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing by Duraiswami Narain at BIOX show?

The Form 3 shows Duraiswami Narain holds stock options over 150,000 Ordinary Shares of Bioceres Crop Solutions. These options carry a $1.50 exercise price and establish his initial reported derivative position as a director.

How many Bioceres (BIOX) shares are covered by Narain’s stock options?

Narain’s options cover 150,000 Ordinary Shares of Bioceres Crop Solutions. This number reflects the underlying shares tied to his derivative position, as disclosed in the Form 3 insider ownership report.

What is the exercise price of Duraiswami Narain’s BIOX stock options?

The exercise price of Narain’s Bioceres stock options is $1.50 per share. This means he can acquire Ordinary Shares at that price once the options become exercisable, assuming he chooses to exercise them.

When do Duraiswami Narain’s Bioceres (BIOX) options become exercisable and when do they expire?

Narain’s options become exercisable on June 30, 2028 and expire on June 30, 2033. This five-year window defines when he can use the options to acquire Ordinary Shares at the stated exercise price.

Are Duraiswami Narain’s reported BIOX option holdings direct or indirect?

The Form 3 states Narain’s stock options are held directly. Direct ownership means the options are owned in his name rather than through an intermediary entity such as a trust, partnership, or family investment vehicle.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 05:20 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Duraiswami Narain

(Last) (First) (Middle)

25 JARED DR

(Street)

ROBINSVILLE NEW JERSEY 08691

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/31/2025

3. Issuer Name and Ticker or Trading Symbol
Bioceres Crop Solutions Corp. [ BIOX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options representing a right to buy	06/30/2028	06/30/2033	Ordinary Shares	150,000	$1.5	D

Explanation of Responses:

	/s/ Narain Duraiswami	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)